» Articles » PMID: 28732072

Placental Peptides Metabolism and Maternal Factors As Predictors of Risk of Gestational Diabetes in Pregnant Women. A Case-control Study

Overview
Journal PLoS One
Date 2017 Jul 22
PMID 28732072
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gestational diabetes is a risk factor for perinatal complications; include shoulder dystocia, birth injuries such as bone fractures and nerve palsies. It is associated with later development of type 2 diabetes, the risk of macrosomia and other long-term health effects of infants born to diabetic mothers. The study assesses placental peptides and maternal factors as potential predictors of gestational diabetes among pregnant women.

Material And Methods: A total of 200 pregnant women were recruited for the study, 150 pregnant women without pre gestational diabetes including 50 women with low risk factors of diabetes as controls and 50 other pregnant women with pregestational diabetes as control. Fasting blood glucose and the lipid profile were determined by enzymatic methods using Envoy® 500 reagents (Vital Diagnostics, USA). Glycated haemoglobin was assessed using the Cation Exchange resin method. Leptin and the Human Placenta Lactogen were assayed using the Sandwich-ELISA technique. Beta chorionic gonadotrophin, insulin, progesterone and estradiol were determined using chemilumiscence imunoassay technique on MAGLUMI 600 analyzer. Anthropometry, including BMI and blood pressure were also measured.

Results: Fasting plasma glucose (FBG), insulin, insulin resistance, glycated haemoglobin and Human Placenta Lactogen(HPL)were significantly (p<0.0001) increased in the pregestational diabetic women whereas progesterone and estradiol were significantly decreased. In the second trimester however, there was no significant difference (p>0.05) in estradiol, insulin, insulin resistance and HPL between the pregnant women who developed gestational diabetes and those who did not. Leptin, progesterone and FBG were significantly increased in those who developed GDM. The risk of developing gestational diabetes increased with overweight (OR = 1.76, P = 0.370) and family history of diabetes (OR = 2.18, P = 0.282).

Conclusion: Leptin, progesterone, estradiol estimated in this study were increased in the gestational diabetes mellitus women and fairly predicted gestational diabetes in the non-diabetics pregnant women. Obesity, aging and family history of diabetes were strongly predictive of gestational diabetes.

Citing Articles

Advancement in predictive biomarkers for gestational diabetes mellitus diagnosis and related outcomes: a scoping review.

Rathnayake H, Han L, da Silva Costa F, Paganoti C, Dyer B, Kundur A BMJ Open. 2024; 14(12):e089937.

PMID: 39675825 PMC: 11647389. DOI: 10.1136/bmjopen-2024-089937.


Fetal sex effects on maternal health can now be tested via randomization: A first-in-class illustration in cows on glucoregulatory outcomes.

Suarez-Trujillo A, Vorland C, Nicholls G, Chusyd D, Parker C, Golzarri-Arroyo L Theriogenology. 2024; 229:41-46.

PMID: 39151322 PMC: 11391945. DOI: 10.1016/j.theriogenology.2024.08.013.


Does the gestational age at which the glucose challenge test (GCT) is conducted influence the diagnosis of gestational diabetes mellitus (GDM)?.

Pardo E, Yagur Y, Gluska H, Cohen G, Kovo M, Biron-Shental T Arch Gynecol Obstet. 2024; 310(3):1593-1598.

PMID: 38987458 DOI: 10.1007/s00404-024-07612-0.


Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in Japan.

Takemoto A, Nagai Y, Kawanabe S, Nakagawa T, Matsumoto K, Hasegawa J Diabetol Int. 2023; 14(4):381-389.

PMID: 37781467 PMC: 10533430. DOI: 10.1007/s13340-023-00646-w.


Elevated Maternal Folate Status and Changes in Maternal Prolactin, Placental Lactogen and Placental Growth Hormone Following Folic Acid Food Fortification: Evidence from Two Prospective Pregnancy Cohorts.

Jankovic-Karasoulos T, Smith M, Leemaqz S, Williamson J, McCullough D, Arthurs A Nutrients. 2023; 15(7).

PMID: 37049394 PMC: 10097170. DOI: 10.3390/nu15071553.


References
1.
. Gestational diabetes mellitus. Diabetes Care. 2002; 23 Suppl 1:S77-9. View

2.
Lee A, Hiscock R, Wein P, Walker S, Permezel M . Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care. 2007; 30(4):878-83. DOI: 10.2337/dc06-1816. View

3.
. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

4.
Sacks D, Arnold M, Bakris G, Bruns D, Horvath A, Kirkman M . Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011; 34(6):e61-99. PMC: 3114322. DOI: 10.2337/dc11-9998. View

5.
Hauguel-de Mouzon S, Guerre-Millo M . The placenta cytokine network and inflammatory signals. Placenta. 2005; 27(8):794-8. DOI: 10.1016/j.placenta.2005.08.009. View